Skip to content

Drug interactions

Lomustine + Olaparib

Severity: Major

Lomustine and Olaparib: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Olaparib commonly causes anemia, neutropenia and thrombocytopenia. Combined with DNA-damaging lomustine, myelosuppression may be more severe and prolonged.

What this interaction means in plain words

Lomustine and Olaparib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Lomustine belongs to Oncology; Olaparib belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive myelosuppression through PARP inhibition and DNA alkylation.

What to do

Monitor blood counts frequently, and consider dose reductions or interruptions for cytopenias. Avoid the combination outside a protocol where possible.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lomustine and Olaparib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Lomustine with Olaparib?

MediHelp rates the interaction as major. Lomustine and Olaparib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Olaparib commonly causes anemia, neutropenia and thrombocytopenia. Combined with DNA-damaging lomustine, myelosuppression may be more severe and prolonged.

How serious is the interaction between Lomustine and Olaparib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts frequently, and consider dose reductions or interruptions for cytopenias. Avoid the combination outside a protocol where possible.

What other medicines interact with Lomustine?

MediHelp also lists interactions of Lomustine with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Lomustine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in